venetoclax
abbvie,roche
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'award', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'venetoclax']
#asco23 david karnofsky award dr kantarjian: 7+3 will likely not be the standard of care for aml nowadays. i believe venetoclax will need to be the backbone in 100% of the patients with aml. 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities